Propanc Biopharma Targets Site of First-In-Human Study for PRP at the Peter Mac Cancer Center, Melbourne, Australia
Initial Discussion Held with Clinical Investigator at Australia’s Biggest Cancer Hospital MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma,…